NCT01999361View on ClinicalTrials.gov

Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss

NARecruitingINTERVENTIONAL

Enrollment

18

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

January 31, 2027

Study Completion Date

December 31, 2028

Conditions

Type 1 Diabetes Mellitus

Interventions

DRUG

Myfortic

treatment with myfortic

Trial Locations (1)

33136

RECRUITING

Diabetes Research Institute, Miami

All Listed Sponsors

lead

Rodolfo Alejandro

OTHER